RBC Capital maintains DuPont de Nemours at Outperform, raises price target to $173 from $160

RBC Capital reaffirmed its Outperform rating for DuPont de Nemours and raised its price target to $173 from $160, suggesting an 8.1% increase. This target implies a 14.8% upside from the Nov 4 close of $150.73. Recent analyst price targets for the company range from $160 to $182.

Original reporting
Published Nov 5, 2026, 6:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 7:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
RBC Capital maintains DuPont de Nemours at Outperform, raises price target to $173 from $160 — source image
Decision brief

The 30-second read

$DDBullishMed
01

Why it matters

The upgrade may prompt short covering and new buying, modestly boosting DD's price.

02

Market read

A modest analyst upgrade that could generate short-term buying interest in DD.

03

What to watch

Potential downside from raw material cost volatility not addressed in the upgrade.

Relevance 6/10Novelty 6/10Timing: today

Background

RBC Capital maintains an Outperform rating on DuPont and adjusts its price target upward.

Company-level read

Ticker impact

$DDBullishHigh confidence
Context

RBC Capital raised DuPont's price target to $173 from $160, indicating a bullish outlook.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

Target increase of 8.1% signals improved expectations, may attract buying.

Market effects

May lift sentiment in the chemicals sector as peers could see similar upgrades.

Limited to US markets where DD trades.

Minor, primarily affects investors tracking DuPont.

Counterpoint

Target raise could be premature if underlying earnings do not meet expectations.

Key entities

  • DuPont de Nemours

    US-listed chemicals and materials company (ticker DD).

  • RBC Capital

    Equity research firm providing the price target revision.

Related articles

$DDMed

Wells Fargo raises DuPont stock price target to $170 on valuation

Wells Fargo raised its price target for DuPont (NYSE:DD) to $170 from $166, maintaining an Overweight rating. The firm cites a higher-quality portfolio and a 2027 EV/EBITDA multiple of 13x. DuPont reported Q3 earnings of $2.09 per share on $1.9B revenue, a 4% increase. UBS also raised its target to $182, citing margin strength. Shares trade at $150.73, with potential upside to $170.

$DDHighAI 9/10

What Just Happened To DuPont Stock?

DuPont (DD) stock rose 8.6% on November 3, 2026, after reporting Q3 2026 earnings of $2.09 per share, beating estimates of $1.87. Sales reached $1.9B, up 4% YoY. The company raised its full-year guidance to $7.50 EPS and $7.19B in sales. Management cited strong order growth but delayed some Middle East projects to 2027. Most peers fell, with only Celanese rising 5.0%.

$DDHighAI 9/10

DuPont de Nemours Q3 Earnings Call Highlights

DuPont (NYSE: DD) reported Q3 Diversified Industrials operating EBITDA up 11% to $242M, with a 24.1% margin. The company highlighted productivity gains, AI initiatives, and raised its 2026 outlook to $7.19B in net sales and $1.785B in EBITDA. Q4 projections include $1.825B in net sales and $455M in EBITDA. DuPont also announced share repurchases and M&A plans.